R1 RCM Inc., a Murray-based provider of practice operations software for healthcare providers, has announced that it has entered into an agreement to be acquired by investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice (CD&R), in an all-cash transaction with an enterprise value of approximately $8.9 billion.
TowerBrook, based in London, England, owned approximately 36 percent of R1 RCM common stock prior to the sale agreement. Under the terms of the agreement, TowerBrook and CD&R, based in New York City, will acquire all of the outstanding common stock that TowerBrook does not currently own for $14.30 per share.
The payment of $14.30 per share in common stock to Please log in to see the rest of this story.
